1. Home
  2. NUWE vs HPK Comparison

NUWE vs HPK Comparison

Compare NUWE & HPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • HPK
  • Stock Information
  • Founded
  • NUWE 1999
  • HPK 2019
  • Country
  • NUWE United States
  • HPK United States
  • Employees
  • NUWE N/A
  • HPK N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HPK Oil & Gas Production
  • Sector
  • NUWE Health Care
  • HPK Energy
  • Exchange
  • NUWE Nasdaq
  • HPK Nasdaq
  • Market Cap
  • NUWE 3.9M
  • HPK N/A
  • IPO Year
  • NUWE N/A
  • HPK N/A
  • Fundamental
  • Price
  • NUWE $0.96
  • HPK $8.76
  • Analyst Decision
  • NUWE Strong Buy
  • HPK Sell
  • Analyst Count
  • NUWE 1
  • HPK 2
  • Target Price
  • NUWE $17.00
  • HPK $11.50
  • AVG Volume (30 Days)
  • NUWE 55.0K
  • HPK 316.9K
  • Earning Date
  • NUWE 05-13-2025
  • HPK 05-12-2025
  • Dividend Yield
  • NUWE N/A
  • HPK 1.84%
  • EPS Growth
  • NUWE N/A
  • HPK N/A
  • EPS
  • NUWE N/A
  • HPK 0.67
  • Revenue
  • NUWE $8,740,000.00
  • HPK $1,069,414,000.00
  • Revenue This Year
  • NUWE $22.96
  • HPK N/A
  • Revenue Next Year
  • NUWE $29.97
  • HPK N/A
  • P/E Ratio
  • NUWE N/A
  • HPK $12.20
  • Revenue Growth
  • NUWE N/A
  • HPK N/A
  • 52 Week Low
  • NUWE $0.75
  • HPK $7.82
  • 52 Week High
  • NUWE $11.55
  • HPK $17.48
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 48.34
  • HPK 39.82
  • Support Level
  • NUWE $0.91
  • HPK $7.87
  • Resistance Level
  • NUWE $1.06
  • HPK $8.25
  • Average True Range (ATR)
  • NUWE 0.08
  • HPK 0.46
  • MACD
  • NUWE 0.01
  • HPK 0.05
  • Stochastic Oscillator
  • NUWE 44.50
  • HPK 27.71

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: